← Leaderboards
Lindsay Gurska
Albert Einstein College Of Medicine
$113,196
Attributed
$113,196
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $46K · FY2020–22$50K$37.5K$25K$12.5K$0
'20
'21
'22
Funding mix
By agency
NIH$113,196 · 1
By mechanism
F31$113,196 · 1
Top collaborators
No co-investigators on record.
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Chandan Guha$30,646,840
- Robert Stanley$95,796
Others in their field
Other Emerging Leaders on “Alternative Splicing”
- Justin B. Kinney · Cold Spring Harbor Laboratory$5,625,506
- Gudrun Stengel · Alida Biosciences, Inc.$4,719,386
- Adam Norris · Southern Methodist University$4,243,750
- Ayellet Vered Segre · Massachusetts Eye And Ear Infirmary$3,794,243
- Rendong Yang · University Of Minnesota$3,719,045
- Georg Seelig · University Of Washington$3,676,436
Research focus
Alternative SplicingBloodBone MarrowBone RemodelingBurden Of IllnessCalreticulinCd34 GeneCell LineCellsChronicClonal Hematopoietic Stem CellClustered Regularly Interspaced Short Palindromic RepeatsCo-ImmunoprecipitationsComorbidityCrizotinibCurative TreatmentsCytokineCytokine Release SyndromeDisease ProgressionDriver MutationElderlyErythroblastsFamilyAcute Erythroblastic Leukemia
Grant awards (3)
RON kinase as a novel therapeutic target in myeloproliferative neoplasms$21,640
F31 · FY2022 · CA · contact PI
RON kinase as a novel therapeutic target in myeloproliferative neoplasms$46,036
F31 · FY2021 · CA · contact PI
RON kinase as a novel therapeutic target in myeloproliferative neoplasms$45,520
F31 · FY2020 · CA · contact PI